AML-1423: National Inpatient Outcomes Following Tagraxofusp Administration for Blastic Plasmacytoid Dendritic Cell Neoplasm and Related Hematologic Malignancies
Year: 2026
Type: conference-abstract
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204687641
